8-K
filed February 17, 2026, 6:59 PM ET
ticker QUCY
CIK 0001874252
other material
confidence high
sentiment neutral
materiality 0.85
Mainz Biomed secures $6M private placement, names David Lazar Chairman; pivots to pancreatic cancer
Quantum Cyber N.V.
- First tranche of $3M closed Feb 13; second $3M expected after shareholder approval by April 15, 2026.
- Preferred shares convertible into up to 95%+ of fully diluted shares; Lazar appointed Chairman and gets board nomination rights.
- Company to focus on U.S. pancreatic cancer detection, evaluate sale of colorectal assets, wind down German sub.
- Settlement agreements with officers/directors require ~$1.9M aggregate payments upon final closing.
Key facts
Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Quantum Cyber N.V. issued 1,000,000 of our series A preferred shares, with a nominal value of €0.01 per share of preferred stock to David E. Lazar for $1.00 per share for aggregate gross proceeds of $3 million.
- Security
- preferred stock
- Shares
- 1,000,000 of our series A preferred shares, with a nominal value of €0.01 per share
- Purchaser
- David E. Lazar
- Consideration
- $1.00 per share for aggregate gross proceeds of $3 million
Exact text from the filing
the Series B Preferred Shares, the “First Closing Shares”), convertible, subject to shareholder approval, into an aggregate of up to 9 million Ordinary Shares in exchange for $3 million; and ● (a) 1,000,000 of our series D preferred shares, with a nominal value of €0.01 per share (the “Series D Preferred Shares”), convertible into an aggregate of up to 225
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Quantum Cyber N.V. issued 1,000,000 of our series C preferred shares, with a nominal value of €0.01 per share of preferred stock to David E. Lazar for $1.00 per share for aggregate gross proceeds of $3 million.
- Security
- preferred stock
- Shares
- 1,000,000 of our series C preferred shares, with a nominal value of €0.01 per share
- Purchaser
- David E. Lazar
- Consideration
- $1.00 per share for aggregate gross proceeds of $3 million
Exact text from the filing
the Series B Preferred Shares, the “First Closing Shares”), convertible, subject to shareholder approval, into an aggregate of up to 9 million Ordinary Shares in exchange for $3 million; and ● (a) 1,000,000 of our series D preferred shares, with a nominal value of €0.01 per share (the “Series D Preferred Shares”), convertible into an aggregate of up to 225
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Quantum Cyber N.V. issued 1,000,000 of our series E preferred shares, with a nominal value of €0.01 per share of preferred stock to David E. Lazar for $1.50 per share for aggregate gross proceeds of $3 million.
- Security
- preferred stock
- Shares
- 1,000,000 of our series E preferred shares, with a nominal value of €0.01 per share
- Purchaser
- David E. Lazar
- Consideration
- $1.50 per share for aggregate gross proceeds of $3 million
Exact text from the filing
The First Closing Shares are subject to certain conversion limitations as described below. Simultaneous to entering into the Purchase Agreement on February 13, 2026, Mr. Lazar purchased the First Closing Shares at a price of $1.00 per share for aggregate gross proceeds of $3 million (the “First Closing”). The Purchase Agreement also contemplates that Mr. Lazar will separately purchase and acquire the Second Closing Shares as soon as practicable after we receive the Conversion Approval (as defined below) at a price of $1.50 per share for aggregate gross proceeds of $3 million
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Quantum Cyber N.V. issued 1,000,000 of our series D preferred shares, with a nominal value of €0.01 per share of preferred stock to David E. Lazar for $1.50 per share for aggregate gross proceeds of $3 million.
- Security
- preferred stock
- Shares
- 1,000,000 of our series D preferred shares, with a nominal value of €0.01 per share
- Purchaser
- David E. Lazar
- Consideration
- $1.50 per share for aggregate gross proceeds of $3 million
Exact text from the filing
The First Closing Shares are subject to certain conversion limitations as described below. Simultaneous to entering into the Purchase Agreement on February 13, 2026, Mr. Lazar purchased the First Closing Shares at a price of $1.00 per share for aggregate gross proceeds of $3 million (the “First Closing”). The Purchase Agreement also contemplates that Mr. Lazar will separately purchase and acquire the Second Closing Shares as soon as practicable after we receive the Conversion Approval (as defined below) at a price of $1.50 per share for aggregate gross proceeds of $3 million
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Quantum Cyber N.V. issued 1,000,000 of our series B preferred shares, with a nominal value of €0.01 per share of preferred stock to David E. Lazar for $1.00 per share for aggregate gross proceeds of $3 million.
- Security
- preferred stock
- Shares
- 1,000,000 of our series B preferred shares, with a nominal value of €0.01 per share
- Purchaser
- David E. Lazar
- Consideration
- $1.00 per share for aggregate gross proceeds of $3 million
Exact text from the filing
the Series B Preferred Shares, the “First Closing Shares”), convertible, subject to shareholder approval, into an aggregate of up to 9 million Ordinary Shares in exchange for $3 million; and ● (a) 1,000,000 of our series D preferred shares, with a nominal value of €0.01 per share (the “Series D Preferred Shares”), convertible into an aggregate of up to 225
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Quantum Cyber N.V. entered into Purchase Agreement with David E. Lazar valued at $3 million (effective 2026-02-13).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- David E. Lazar
- Value
- $3 million
- Effective
- 2026-02-13
Exact text from the filing
On February 13, 2026, we entered into a Securities Purchase Agreement (the “Purchase Agreement”) with David E. Lazar that provides for the sale in a private placement of:
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.